Given the potential role of RIPK1 in glioma immunity due to its role in necroptosis and pyroptosis, we performed a meta-analysis using previously validated immune genetic signatures of tumor-infiltrating immune cells [34,35]. This evidence concerns the gene RIPK1 and neoplasm.